Publication | Open Access

Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial

Checkmate 025UrologyGenitourinary CancerMedicineCancer TreatmentOncologyNivolumab Versus Everolimus